Application of Individualized Treatment for MDS: Expert Guidance for Clinical Practice

Download All
Improve your ability to tailor MDS treatment to individual patients with a webcast of a live meeting, an audio podcast, downloadable slides, expert commentaries, and a new decision support tool.
Amy E. DeZern, MD, MHS
Daniel Pollyea, MD, MS
Amer Zeidan, MBBS, MPH


In this commentary, Daniel A. Pollyea, MD, MS, provides his strategies for treating patients with myelodysplastic syndrome.

Daniel Pollyea, MD, MS Released: September 24, 2021

In this commentary, Amer M. Zeidan, MBBS, reviews the latest novel and investigational treatments for patients with myelodysplastic syndromes.

Amer Zeidan, MBBS, MPH Released: November 22, 2021

In this commentary, Amy E. DeZern, MD, MHS, highlights the clinical implications of trials of novel treatment strategies for myelodysplastic syndromes reported at ASH 2021.

Amy E. DeZern, MD, MHS Released: February 16, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Bristol-Myers Squibb
Gilead Sciences, Inc.
Novartis Pharmaceuticals Corporation
Taiho Oncology Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings